No dips to buy?, developing the vaccine and a big ransomware target
CNBC
‘Buying the dip’ is something we’re often told from Wall Street strategists. But what if there aren’t any dips to buy? We’ll discuss. Plus, we’ll speak with one of the key researchers behind the Pfizer vaccine about the breakthrough technology and why she’s not concerned about variants. And, as Apple announced its new product lineup, a key supplier was suffering a multibillion dollar ransomware attack aimed at stealing Apple’s blueprints. We’ll explain.